Artificial Heart Market size was valued at 2.82 Billion in 2021 and is estimated to reach 7.63 Billion by 2028, at a CAGR of 15.3% during the forecast period 2022 to 2028. Limited availability of donors, on spot availability of fresh organs had limited the rate of orthotropic heart transplantations. High chances of non-suitability of available organs due to blood groups, age and high risk of transplantation due to high pulmonary vascular resistance of patients leads in increasing number of patients for organs than with donors which leads to high increase in demand for artificial heart devices. Although high cost procedures, stringent regulatory scenarios are restraining the market in some cases. Global artificial heart market is surging owing to frequent acquisitions and launchings by the market players. For instance, In August 2019 researchers at The University of Birmingham have developed a device that could improve care for patients with artificial heart pumps. Also non-blood contacting devices are developing which will enhance the market.